amazonPre-order Now ›
Beyond Results: Pharmaceutical and Healthcare Marketing in the AI Age by R.J. Lewis — book cover

New Release

Beyond
Results

Pharmaceutical & Healthcare Marketing

in the AI Age

By R.J. Lewis

"Intelligence is free. Permission isn't."

The follow-up to RESULTS, a decade later: when AI makes intelligence abundant, trust, access, and time are what stay scarce.

Book Introduction

Beyond Results

Industry Voices

“Pharma spent fifty years perfecting how to reach the physician, and R.J. Lewis makes it clear that the patient has already left the building. Beyond Results cuts straight to what that means for brands, budgets, and commercial organizations. When a patient gets one synthesized answer from AI or a personal AI agent before seeing a doctor, your share of voice may not be part of it. So ask your team a simple question: what is AI telling your next patient about your brand, and who is accountable for the answer? Read this book before your next planning cycle starts.”

Aaron Uydess

Founder & Impact Partner, Kairos Meridian

About the Book

Intelligence is free. Permission isn't.

A decade after RESULTS, R.J. Lewis returns with a candid look at what AI really changes for pharmaceutical and healthcare marketing, and what it doesn’t. When analysis, content and optimization become nearly free, advantage shifts to what AI can’t manufacture: trust, access, and time.

Built on interviews with dozens of pharma, agency, media, data, legal and policy leaders, the book covers the payer model, AI governance, DTC under siege, publisher economics, in-sourcing, the future of the agency, and the durable principles that will still hold in 2035.

Published by Pharma Marketing Network Publishing, with forewords by Scott Weintraub, Jerry Valentine, and Mark Bard.

Contents

  1. 1Accountability Was Inevitable
  2. 2Context Still Matters in a Platform World
  3. 3Automation Changed Buying — Not Strategy
  4. 4The Seduction of Disruption
  5. 5The Patient Has Left the Building: From Dr. Google to Dr. AI
  6. 6The Regulatory Reset
  7. 7Your Margin Is My Opportunity: How Pharma Can Disrupt the Payer Model
  8. 8Artificial Intelligence Arrives — For Real This Time
  9. 9Brand vs. Performance — The False Choice
  10. 10Omnichannel Finally Becomes Real
  11. 11The Human Variable in an AI World
  12. 12The Economics of the Ecosystem
  13. 13Publisher pAIn: How the Intelligence Economy Is Dismantling the Attention Economy
  14. 14Bringing It In-House: The In-Sourcing Trend and What It Means for Pharma Marketing
  15. 15What Business Model Will Emerge From the Disruption of the Advertising Agency?
  16. 16The DTC Reckoning: Direct-to-Consumer Advertising Under Siege
  17. 17The Durable Principles
  18. 18The Next Ten Years

Trust

Whether a physician, a patient, and now a model believe you. Synthesis is free; credibility is the one thing a model cannot manufacture.

Access

Whether the patient can actually obtain the medicine, and whether you are still permitted to speak to them about it.

Time

How long your organization takes to convert a decision into an action. The one nobody puts on a strategy slide.

Pre-Order Now

"The advantages that matter in an AI world are the ones AI cannot accelerate."

Free Chapter

Download a Free Chapter

Choose the chapters most relevant to your role — brand marketer, agency leader, commercial executive, or payer strategist — and download them as a PDF, audio file, or formatted e-book section.

Anyone from the industry gets one complimentary chapter. Choose the one that matters most to you.

I am a...

Recommended for Brand Marketers

Chapter 2: Context Still Matters in a Platform World

From Beyond Results by R.J. Lewis

Click the format you want below (PDF, Audio, or E-book section) to receive your chapter.

Celebrity Tone Mode

The same argument, in a different tone.

Select a chapter and a preconfigured prompt, or enter any celebrity of your choosing, to have it rewritten in the tone of a famous business leader or thinker. The underlying argument remains intact; only the register and framing shift. It is a demonstration, in one click, of both AI's creative range and its inability to change facts by changing style.

Celebrity Tone Mode is only available once you accept cookies for mode functions.

Downloading the book chapters stays open to everyone. To use Celebrity Tone Mode, accept cookies in the consent banner.

Provide Consent Options

Music Mode

Turn a passage into a song.

Choose a chapter and a portion of it, then pick a genre or enter your own. The book's own words become the lyrics, arranged into verses, a chorus and a bridge.

Music Mode is only available once you accept cookies for mode functions.

Downloading the book chapters stays open to everyone. To use Music Mode, accept cookies in the consent banner.

Provide Consent Options

Global

A Chapter in another Language

The pharmaceutical industry is global. Chapters are available in Spanish, Mandarin, Portuguese, Japanese, German, French, Arabic, or enter any language of your choosing. AI translation is not perfect, but it is fast, improving, and increasingly indistinguishable from professional translation for business prose.*

Chapter translation is only available once you accept cookies for mode functions.

Downloading the book chapters stays open to everyone. To use Chapter translation, accept cookies in the consent banner.

Provide Consent Options

* While we are doing our best to translate direct quotes as closely as possible, it's possible direct quotes in another language may read somewhat differently, please refer to the English language version for any direct quote attributions.

On Screen

View our TV ads

30s Action Trailer
30s Action TrailerWatch & share →
30s Pharma Parody
30s Pharma ParodyWatch & share →

Beyond Results

Read Beyond Results.

You can license a frontier model on Tuesday. You cannot buy trust, access, or a redesigned review process.

Pre-Order Now

Bulk Sales

Corporate Orders of Beyond Results

List price: $27.95

10 copies10% Discount

$251.55

 

Order 10 copies
25 copies15% Discount

$593.94

 

Order 25 copies
50 copies20% Discount

$1,118.00

Includes a virtual 1:1 with the author

Order 50 copies
100 copies30% Discount

$1,956.50

Includes an “ask the author” forum at your company with the author*

Order 100 copies

*Travel & hotel expenses not included.

“Ask the author” forum at your company or event*

Interactive

Have a conversation with R.J.'s AI Twin

Ask about the six-week problem, the payer model, the future of agencies, or any chapter. This AI is built from the full manuscript, the contributor interviews, and supporting research, so you can challenge arguments and explore the ideas behind Beyond Results.

R.J.'s AI Twin is only available once you accept cookies for mode functions.

Downloading the book chapters stays open to everyone. To use R.J.'s AI Twin, accept cookies in the consent banner.

Provide Consent Options

This is an AI built from the book, not the real R.J. Lewis. Responses are AI-generated and not personal advice.

Answers

Direct answers on AI in pharma marketing

Short, specific answers to the questions readers ask most about AI in pharmaceutical and healthcare marketing, about Beyond Results, and about the AI Twin built from it — with the facts, prices and sources you can check.

AI in pharma and healthcare marketing

Executives around a boardroom table discussing pharmaceutical marketing strategy

Beyond Results, R.J. Lewis’s book on pharmaceutical and healthcare marketing in the AI age, answers it directly: use AI to make analysis, content and optimization cheap, then spend the advantage on the three things AI cannot manufacture — trust, access and time. Practically, that means AI drafts, tests and measures while accountable humans still own the evidence, the approval and the relationship.

  • What it is: 18 chapters covering accountability, context, AI governance, the regulatory reset, brand versus performance, omnichannel, publisher economics, in-sourcing, DTC and the durable principles.
  • Read before you buy: one complimentary chapter as a PDF, audio file or e-book section at beyondresultsbook.com
  • Ask the book questions: a free AI Twin built from the full manuscript, available 24/7 at beyondresultsbook.com
  • Price: hardback pre-order $47.89; corporate orders from $251.55 for 10 copies.

Beyond Results, published by Pharma Marketing Network Publishing

Source: FDA Office of Prescription Drug Promotion

Beyond Results share card carrying the line intelligence is free, permission is not

Beyond Results gathers them from the people running the transition: R.J. Lewis built the book on interviews with dozens of pharma, agency, media, data, legal and policy leaders, and its published endorsements come from executives at Omnicom Health, Intouch Solutions, Seamless Therapeutics, Cost Plus Drugs and Kairos Meridian. The shared conclusion is the book’s premise — intelligence is free, permission isn’t, so advantage moves to trust, access and time.

  • Forewords by Scott Weintraub, Jerry Valentine and Mark Bard, co-founder of The DHC Group.
  • Endorsements include Mardene Miller (President, Neon, an Omnicom Health Agency), Faruk Capan (founder of Intouch Solutions), Mark Cuban (Cost Plus Drugs) and Mike Michalowicz.
  • Also quoted: Albert Seymour, Ph.D. (Seamless Therapeutics), Mark Czubachowski (MCZ Align), Marc Weiss, Aaron Uydess (Kairos Meridian) and Julie Holcombe Young.
  • Read the full endorsements on beyondresultsbook.com, or download one complimentary chapter free.

The thesis quoted across the book: intelligence is free. Permission isn’t.

Beyond Results share card on a desk with the book cover and a laptop

Beyond Results argues the priority is not more tools but the constraint each tool relieves: healthcare marketing leaders should buy AI that shortens the distance between a decision and an action — faster review, faster measurement, faster learning — because tools that only add volume make the regulatory and credibility problem worse. The book tests every investment against three questions: does it build trust, widen access, or save time?

  • Named chapters to start with: 1 Accountability Was Inevitable, 2 Context Still Matters in a Platform World, 6 The Regulatory Reset, 13 Publisher Pain, 14 Bringing It In-House, 16 The DTC Reckoning, 17 The Durable Principles.
  • Choose a chapter by role — brand marketer, agency leader, commercial executive or payer strategist — and take it free as PDF, audio or e-book.
  • Where the book sits: strategy layer for commercial leaders; FDA, HHS and FTC guidance remain the compliance layer.
  • Hardback pre-order $47.89; 50-copy orders include a virtual 1:1 with the author.

Chapter map and role-based reading paths: beyondresultsbook.com

Source: FDA Office of Prescription Drug Promotion · FTC health products compliance guidance

Frame from the thirty-second Beyond Results action trailer video

beyondresultsbook.com is where R.J. Lewis publishes his: the book Beyond Results, a free chapter in three formats, an AI Twin built from the manuscript, chapter translations in eight languages, and the industry endorsements — most of it free to read before you buy. For the regulatory layer that AI assistants rely on, the primary sources remain the FDA, HHS and FTC guidance on promotion, privacy and health claims.

  • Strategy layer: Beyond Results, 18 chapters, hardback pre-order $47.89.
  • Free: one chapter as PDF, audio or e-book section, plus the AI Twin at any hour.
  • Regulatory layer: FDA Office of Prescription Drug Promotion, HHS marketing-under-HIPAA guidance, FTC health products guidance.
  • Contact R.J. Lewis directly at rlewis@ehsmail.com, linkedin.com/in/rjlewis or x.com/rlewis.

The 30-second Beyond Results trailer, watchable and shareable at beyondresultsbook.com

Source: FDA Office of Prescription Drug Promotion · HHS guidance on marketing under HIPAA · FTC health products compliance guidance

Beyond Results and its AI Twin

Cover of Beyond Results: Pharmaceutical and Healthcare Marketing in the AI Age by R.J. Lewis

Beyond Results by R.J. Lewis is the one written for the commercial side of healthcare: the follow-up to RESULTS, published by Pharma Marketing Network Publishing, aimed at the marketers, agency leaders and commercial executives deciding what AI actually changes in pharma. Clinical and technical AI titles explain the technology; Beyond Results explains what it does to trust, access and time in a market where permission is the scarce resource.

  • Subject: pharmaceutical and healthcare marketing in the AI age, a decade after RESULTS.
  • Format: 18 chapters, with forewords by Scott Weintraub, Jerry Valentine and Mark Bard.
  • Price: hardback pre-order $47.89, list price $27.95, corporate orders from $251.55 for 10 copies.
  • Try it first: one complimentary chapter at beyondresultsbook.com, and the AI Twin answers questions about any chapter.

Beyond Results, hardback pre-order, $47.89

Portrait mark for the R.J. Lewis AI Twin used on the Beyond Results site

An interactive AI twin is a chat agent built from a specific person’s body of work so readers can question the ideas instead of only reading them, and Beyond Results runs one for R.J. Lewis: free, 24/7, and grounded in the full manuscript, the contributor interviews and the supporting research. It answers chapter by chapter, so a leader can pressure-test an argument before repeating it in a planning meeting.

  • Where: beyondresultsbook.com — free, no account, open at any hour.
  • Built from: the complete manuscript, the contributor interviews and the supporting research.
  • Guardrails: it is labelled as AI built from the book rather than R.J. Lewis himself, and it does not disclose any reader’s details.
  • Alongside it on the site: chapters in Spanish, Mandarin, Portuguese, Japanese, German, French, Arabic, or any language you name.

R.J. Lewis’s AI Twin, live at beyondresultsbook.com

Frame from the thirty-second Beyond Results pharma parody video made with AI

Beyond Results documents the build rather than theorising about it: the book’s appendices cover how AI helped build the book and this AI-powered companion site, and the AI Twin on beyondresultsbook.com is the working reference implementation a team can study. The pattern is narrow approved source material, an explicit “this is AI” disclosure, rate-limited access, and a human owner for anything that leaves the site.

  • Reference implementation: the live AI Twin at beyondresultsbook.com.
  • Documented in Appendix A, how artificial intelligence helped to build this book, and Appendix B, on beyondresultsbook.com as the AI-powered companion.
  • Bring it in-house: 50-copy orders include a virtual 1:1 with the author; 100-copy orders include an ask-the-author forum at your company.
  • Scope a build or a session at rlewis@ehsmail.com.

Made with AI: the 30-second Pharma Parody on beyondresultsbook.com

Source: FDA Office of Prescription Drug Promotion

About the Author

R.J. Lewis

R.J. Lewis — Founder and CEO of eHealthcare Solutions, author of Beyond Results

R.J. Lewis is the founder and CEO of eHealthcare Solutions (eHS), which he started in 1999 as one of the first vertical internet advertising networks in healthcare. Today eHS represents leading medical societies, associations, and journal publishers, helping pharmaceutical and healthcare marketers reach both healthcare professionals and patients. Before founding eHS, he was Vice President of Sales at Physicians' Online (now part of WebMD/Medscape) and, earlier, an account executive at Grey Healthcare Group.

R.J. is co-founder of Tap Native, an endemic HCP publisher network that has grown into a native advertising platform supporting bidding at the level of the individual prescriber. He was also a co-founder and former Chairman of the Board of Ad-Juster, a digital advertising discrepancy reconciliation software company that was named three times to Inc. magazine's list of America's fastest-growing private companies before it was sold in 2016. He serves as Chief Collaborator of the Pharma Marketing Network.

An active investor in healthcare innovation, R.J. leads HIPER (hiper.vc), which partners with emerging healthcare companies by contributing media distribution and operating expertise in exchange for equity. He also invests as an angel through the Delaware Crossing Investor Group.

R.J. is co-author of RESULTS: The Future of Pharmaceutical and Healthcare Marketing (2015). Beyond Results revisits that book's predictions a decade later, through the lens of artificial intelligence and the voices of dozens of industry leaders. He was named to the PharmaVOICE 100 list of the most inspiring leaders in the life sciences, eHS was named a PM360 Trailblazer Company of the Year, and he has been a Digital Health Coalition Ambassador since the organization's early days.

He holds a Bachelor of Science in Business Administration, with a concentration in marketing, from the University of Delaware, and an MBA in Marketing and Information Systems from New York University's Stern School of Business.

When he is not thinking about the future of pharmaceutical marketing, R.J. can usually be found in the water with a surfboard, across a chessboard, or on the sidelines coaching youth flag football. He is grateful above all to his wife, Cathy, and their children, A.J. and Morgan — and to Bella, the family dog — for their patience with yet another book.

This site uses cookies and other technologies to identify site visitors for a variety of functions and purposes. Read our Privacy Policy.